PT - JOURNAL ARTICLE AU - MASAMICHI HAYASHI AU - SUGURU YAMADA AU - NAO TAKANO AU - YUKIYASU OKAMURA AU - HIDEKI TAKAMI AU - YOSHIKUNI INOKAWA AU - FUMINORI SONOHARA AU - NOBUTAKE TANAKA AU - DAI SHIMIZU AU - NORIFUMI HATTORI AU - MITSURO KANDA AU - CHIE TANAKA AU - GORO NAKAYAMA AU - MASAHIKO KOIKE AU - YASUHIRO KODERA TI - Different Characteristics of Serum Alfa Fetoprotein and Serum Des-gamma-carboxy Prothrombin in Resected Hepatocellular Carcinoma AID - 10.21873/invivo.12434 DP - 2021 May 01 TA - In Vivo PG - 1749--1760 VI - 35 IP - 3 4099 - http://iv.iiarjournals.org/content/35/3/1749.short 4100 - http://iv.iiarjournals.org/content/35/3/1749.full SO - In Vivo2021 May 01; 35 AB - Background/Aim: Hepatocellular carcinoma (HCC) mainly develops in the damaged liver from hepatitis C virus (HCV) or hepatitis B virus (HBV) infection in Japan. On the other hand, the occurrence of HCCs derived from the liver without viral infection has recently been increasing. Our aim was to identify characteristics specific to HCCs with virus-infected liver (HCC-BC) or those with non-B- and non-C-infected liver (HCC-NBNC), Patients and Methods: We collected preoperative serum α-fetoprotein (AFP) and Des-Gamma-Carboxy Prothrombin (DCP), also known as PIVKA-II values from surgically resected HCC cases during 1994-2017 in our department. Results: Preoperative serum AFP values of HCC-BC cases (n=284) were higher compared to HCC-NBNC cases (n=88) (p=0.016), whereas serum DCP values of HCC-NBNC cases were higher compared to HCC-BC cases (p<0.001). Multivariable analyses indicated that abnormal serum AFP [hazard ratio (HR)=1.46, 95% conficdence interval (CI)=1.03-2.07, p=0.035) was one of the significant recurrence-free survival predictors of HCC-BC cases, while abnormal serum DCP (HR=4.99, 95%CI=1.91-13.01, p=0.001) was one of the significant recurrence-free survival predictors of HCC-NBNC cases. Conclusion: HCC-NBNC cases have a different tumor marker profile from HCC-BC cases. Elevated DCP could be both a diagnostic and prognostic marker of HCC-NBNC patients.